Sectoral Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Sectoral Asset Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-47,500	Closed	-$4.84M	–	136
2023 Q2	$4.84M	Buy	47,500 +22,500	+90%	+$2.13M	0.81%	59
2023 Q1	$2.27M	Buy	+25,000	New	+$1.47M	0.44%	77
2020 Q3	–	Sell	-3,600	Closed	-$562K	–	188
2020 Q2	$562K	Sell	3,600 -70,409	-95%	-$10.7M	0.05%	129
2020 Q1	$10.7M	Sell	74,009 -6,641	-8%	-$1.28M	2.05%	15
2019 Q4	$16.5M	Buy	+80,650	New	+$14.7M	2.46%	10

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sectoral Asset Management's RETA Position: Q3 2023 in Review

Sectoral Asset Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 47,500 shares — an estimated $4.84M sold.

Sectoral Asset Management first reported a position in RETA in Q4 2019 and held it in 5 quarters. The position peaked at $16.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Sectoral Asset Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Sectoral Asset Management sold 47,500 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.84M.
Sectoral Asset Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 5 quarters.
Sectoral Asset Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $16.5M in Q4 2019.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.